2017-03-01
News
Category: News
2016-09-21
News
A series of trials have been conducted at the Animal Health Trust, Newmarket, England. The trials were aimed to measure the safety, immunogenicity, efficacy and DIVA (differentiates infected from vaccinated animals) ... Read more
2015-10-28
News
Intervacc is pleased to announce that an agreement has now been signed with PX´Therapeutics, Grenoble, France, for process optimization of Strangvac. PX´Therapeutics, a subsidiary of Aguettant pharmaceutical group, has the ... Read more
2015-08-10
News
The recognized journal Animal Pharm once again highlights Strangvac® in an article about the research now approaching a solution regarding effective vaccine protection against strangles.
The ... Read more